Allergic rhinitis (AR) is an inflammatory nasal condition linked to allergens, and this study is the first to document familial success with allergen desensitization therapy (SCIT).
A month-long survey of 200 SCIT patients revealed that 26% reported family members also benefiting from the same treatment.
Understanding genetic influences on SCIT effectiveness could enhance treatment recommendations for AR patients in the future.